Canaccord Genuity on Life Sciences/Specialty Pharma: Columbia Labs Management Call - PROCHIEVE Update with Implications for BUY-rated Watson (WPI)
Go back to Canaccord Genuity on Life Sciences/Specialty Pharma: Columbia Labs Management Call - PROCHIEVE Update with Implications for BUY-rated Watson (WPI)| COLUMBIA LABORATOR (NYSE: CBRX) | Delayed: 13.64 -1.65 (10.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.29 | 52 Week High | $8.40 | |||
| Open | $14.49 | 52 Week Low | $5.09 | |||
| Day High | $14.94 | P/E | 44.00 | |||
| Day Low | $13.34 | EPS | $0.31 | |||
| Volume | 419,122 | |||||
| Watson Pharmaceuticals, Inc. (NYSE: WPI) | Delayed: 85.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.73 | 52 Week High | $91.47 | |||
| Open | $16.30 | 52 Week Low | $57.16 | |||
| Day High | $85.73 | P/E | 66.46 | |||
| Day Low | $85.73 | EPS | $1.29 | |||
| Volume | 3,625 | |||||
